Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 EUR | +3.47% | -2.03% | +12.40% |
Mar. 15 | RBC Cuts Price Target on aTyr Pharma to $16 From $19, Keeps Outperform Rating, Speculative Risk Qualifier | MT |
Mar. 14 | Transcript : ATyr Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
- Stock Market
- Equities
- LIFE Stock
- 471A Stock
- News aTyr Pharma, Inc.